ketosteril potahovaná tableta
fresenius kabi deutschland gmbh, bad homburg array - 4627 kalcium-beta-methyloxovalerÁt; 4722 kalcium-gama-methyloxovalerÁt; 4652 kalcium-methyloxobutyrÁt; 4653 kalcium-oxofenylpropionÁt; 4654 kalcium-hydroxymethylthiobutyrÁt; 4565 lysin; 1459 threonin; 1503 tryptofan; 717 histidin; 1507 tyrosin - potahovaná tableta - aminokyseliny vČetnĚ kombinacÍ s polypeptidy
tyenne
fresenius kabi deutschland gmbh - tocilizumab - arthritis, rheumatoid; cytokine release syndrome; arthritis, juvenile rheumatoid; covid-19 virus infection; giant cell arteritis - imunosupresiva - tyenne, in combination with methotrexate (mtx), is indicated for- the treatment of severe, active and progressive rheumatoid arthritis (ra) in adults not previously treated with mtx. - the treatment of moderate to severe active ra in adult patients who have either responded inadequately to, or who were intolerant to, previous therapy with one or more disease-modifying anti-rheumatic drugs (dmards) or tumour necrosis factor (tnf) antagonists. in these patients, tyenne can be given as monotherapy in case of intolerance to mtx or where continued treatment with mtx is inappropriate. tocilizumab has been shown to reduce the rate of progression of joint damage as measured by x-ray and to improve physical function when given in combination with methotrexate. tyenne is indicated for the treatment of coronavirus disease 2019 (covid-19) in adults who are receiving systemic corticosteroids and require supplemental oxygen or mechanical ventilation. tyenne is indicated for the treatment of active systemic juvenile idiopathic arthritis (sjia) in patients 1 year of age and older, who have responded inadequately to previous therapy with nsaids and systemic corticosteroids. tyenne can be given as monotherapy (in case of intolerance to mtx or where treatment with mtx is inappropriate) or in combination with mtx. tyenne in combination with methotrexate (mtx) is indicated for the treatment of juvenile idiopathic polyarthritis (pjia; rheumatoid factor positive or negative and extended oligoarthritis) in patients 2 years of age and older, who have responded inadequately to previous therapy with mtx. tyenne can be given as monotherapy in case of intolerance to mtx or where continued treatment with mtx is inappropriate. tyenne is indicated for the treatment of chimeric antigen receptor (car) t cell-induced severe or life-threatening cytokine release syndrome (crs) in adults and paediatric patients 2 years of age and older. tyenne is indicated for the treatment of giant cell arteritis (gca) in adult patients.
ozurdex
abbvie deutschland gmbh & co. kg - dexamethason - macular edema; uveitis - ophthalmologicals, other ophthalmologicals - ozurdex je indikován k léčbě dospělých pacientů s makulární edém po jedné větve sítnicové žilní okluze (brvo) nebo centrální retinální žíly okluze (crvo). ozurdex je indikován k léčbě dospělých pacientů se zánětem zadního segmentu oka, projevující se jako neinfekční uveitida. ozurdex je indikován k léčbě dospělých pacientů s poškozením zraku v důsledku diabetického makulárního edému (dme), kteří jsou pseudofakičtí nebo kteří jsou považováni za dostatečně citlivý, nebo nevhodné pro non-kortikosteroidní terapie.
betadine 100mg/g mast
egis pharmaceuticals plc, budapešť array - 2571 jodovanÝ povidon - mast - 100mg/g - jodovanÝ povidon
betadine 100mg/ml kožní roztok
egis pharmaceuticals plc, budapešť array - 2571 jodovanÝ povidon - kožní roztok - 100mg/ml - jodovanÝ povidon
betadine 200mg Čípek
egis pharmaceuticals plc, budapešť array - 2571 jodovanÝ povidon - Čípek - 200mg - jodovanÝ povidon
betadine 75mg/ml kožní roztok
egis pharmaceuticals plc, budapešť array - 2571 jodovanÝ povidon - kožní roztok - 75mg/ml - jodovanÝ povidon
braunol 75mg/g kožní roztok
b. braun melsungen ag, melsungen array - 2571 jodovanÝ povidon - kožní roztok - 75mg/g - jodovanÝ povidon
braunovidon 100mg/g mast
b. braun melsungen ag, melsungen array - 2571 jodovanÝ povidon - mast - 100mg/g - jodovanÝ povidon
jodisol 38,5mg/g kožní roztok
spofadental a.s., jičín array - 2571 jodovanÝ povidon - kožní roztok - 38,5mg/g - jodovanÝ povidon